Library
BCM-95® (CURCUGREEN®), 07 Aug 2021
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo-controlled clinical trial
Saeede Saadati, Amir Sadeghi, Asieh Mansour, Zahra Yari, Hossein Poustchi, Mehdi Hedayati, Behzad Hatami and Azita Hekmatdoost
Doi: 10.1186/s12876-019-1055-4
Background: The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic features in patients with non-alcoholic fatty liver disease (NAFLD).
Methods: Fifty patients with NAFLD were randomized to receive lifestyle modification advice plus either 1500 mg curcumin or the same amount of placebo for 12 weeks.
Results: Curcumin supplementation was associated with significant decrease in hepatic fibrosis (p < 0.001), and nuclear factor-kappa B activity (p < 0.05) as compared with the baseline. Hepatic steatosis and serum level of liver enzymes, and tumor necrosis-α (TNF-α) significantly reduced in both groups (p < 0.05). None of the changes were significantly different between two groups.
Conclusion: Our results indicated that curcumin supplementation plus lifestyle modification is not superior to lifestyle modification alone in amelioration of inflammation.
Trial registration: IRCT20100524004010N24, this trial was retrospectively registered on May 14, 2018.
(https://doi.org/10.1186/s12876-019-1055-4)
Keywords:
Keywords
- NASH
- study.no.63
Request More Information
Increase your business growth potential with our patented extracts
Let’s collaborate to refine your ideas or built from scratch
Arjuna Natural
Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown...Read More
